The store will not work correctly when cookies are disabled.
6-chloro-3-(1-methyl-1-phenylethyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
ID: ALA212041
PubChem CID: 135410912
Max Phase: Preclinical
Molecular Formula: C14H14ClN3O2S2
Molecular Weight: 355.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(NC1=NS(=O)(=O)c2sc(Cl)cc2N1)c1ccccc1
Standard InChI: InChI=1S/C14H14ClN3O2S2/c1-14(2,9-6-4-3-5-7-9)17-13-16-10-8-11(15)21-12(10)22(19,20)18-13/h3-8H,1-2H3,(H2,16,17,18)
Standard InChI Key: XUSQKHZVTSWKMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
9.3851 -19.2396 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.0976 -18.8333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0976 -18.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3851 -17.5897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8879 -19.0856 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.6725 -18.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6725 -18.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8870 -17.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4069 -18.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9660 -19.8241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7969 -19.8241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8138 -17.5958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5819 -18.4237 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.5276 -18.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2439 -17.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9544 -18.0203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6659 -17.6085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6687 -16.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9542 -16.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2413 -16.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1051 -18.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9401 -18.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
1 11 2 0
3 12 1 0
7 4 1 0
9 13 1 0
6 1 1 0
12 14 1 0
1 2 1 0
14 15 1 0
2 3 2 0
15 16 2 0
5 6 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
3 4 1 0
14 21 1 0
1 10 2 0
14 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.87 | Molecular Weight (Monoisotopic): 355.0216 | AlogP: 3.40 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.01 | CX Basic pKa: 1.44 | CX LogP: 3.54 | CX LogD: 3.54 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.87 | Np Likeness Score: -1.16 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |